Bringing Onco-Innovation to Europe’s Healthcare Systems: The Potential of Biomarker Testing, Real World Evidence, Tumour Agnostic Therapies to Empower Personalised Medicine

SIMPLE SUMMARY: The increasing number of data supporting use of a personalized approach in cancer treatment, is changing the path of patient’s management. In the same time, the availability of technologies should allow patients to receive the best test for the specific individual condition. This is...

Descripción completa

Detalles Bibliográficos
Autores principales: Horgan, Denis, Ciliberto, Gennaro, Conte, Pierfranco, Curigliano, Giuseppe, Seijo, Luis, Montuenga, Luis M., Garassino, Marina, Penault-Llorca, Frederique, Galli, Fabrizia, Ray-Coquard, Isabelle, Querleu, Denis, Riegman, Peter, Kerr, Keith, Van Poppel, Hein, Bjartell, Anders, Codacci-Pisanelli, Giovanni, Koeva-Balabanova, Jasmina, Paradiso, Angelo, Maravic, Zorana, Fotaki, Vassiliki, Malats, Nuria, Bernini, Chiara, Buglioni, Simonetta, Kent, Alastair, Munzone, Elisabetta, Belina, Ivica, Van Meerbeeck, Jan, Duffy, Michael, Jagielska, Beata, Capoluongo, Ettore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Guidelines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867284/
https://www.ncbi.nlm.nih.gov/pubmed/33540773
http://dx.doi.org/10.3390/cancers13030583

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867284/
https://www.ncbi.nlm.nih.gov/pubmed/33540773
http://dx.doi.org/10.3390/cancers13030583

Ejemplares similares